Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

HM43239, a Novel Small Molecule Inhibitor of FLT3, in Acute Myeloid Leukemia (AML) with and without FMS-like Tyrosine Kinase 3 (FLT3) Mutations: Phase 1/2 Study

Naval Daver, MD, Kyoo Hyung Lee, MD PhD, Chul Won Jung, MD PhD, Yoon Sung Soo, MD PhD, Martha L. Arellano, MD, Brian A Jonas, MD PhD, Jiyeon Yoon, PhD, Sooa Jung, PhD, Young Su Noh, PhD, Inhwan Bae, PhD, Song Kim, MD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-143244

Published: 2020

Journal Articles

Machine Learning-Based Approach to Predict Survival after Allogeneic Hematopoietic Cell Transplantation in Hematologic Malignancies

Eun-Ji Choi, MDPhD, Je-Hwan Lee, MDPhD, Jun-Hong Park, MD, Han-Seung Park, MD, Jung-Hee Lee, MD PhD, Youngshin Lee, Young-Ah Kang, Mijin Jeon, Ji Min Woo, Hyeran Kang, Kyoo Hyung Lee, MD PhD

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-142337

Published: 2020

Journal Articles

HM43239, a Novel Potent Small Molecule FLT3 Inhibitor, in Acute Myeloid Leukemia (AML) with FMS-like Tyrosine Kinase 3 (FLT3) Mutations: Phase 1 /2 Study

Naval G. Daver, MD, Kyoo Hyung Lee, MD PhD, Sung-Soo Yoon, MD PhD, Chul Won Jung, MD PhD, Hyun Jeong Kang, Sooa Jung, Sujin Seo, Jiyeon Yoon, Hyunjin Kim, Young Su Noh, Yoonha Seo, Hyeyoung Kwon, Oakpil Han, Seungjae Baek, MD PhD, Kyounghee Seo, Kwee Hyun Suh, PhD

Blood (2019) 134 (Supplement_1): 1331.

https://doi.org/10.1182/blood-2019-129670

Published: 2019

Journal Articles

Long-Term Outcomes of Chronic Myeloid Leukemia Patients Who Lost Undetectable Molecular Residual Disease (UMRD) after Imatinib Discontinuation: Korean Imatinib Discontinuation Study (KIDS)

Sung-Eun Lee, MD, Joon Seong Park, MD, Hyeoung-Joon Kim, MD PhD, Sung-Hyun Kim, MD PhD, Dae Young Zang, MD PhD, Sukjoong Oh, MD PhD, Young Rok Do, PhDMD, Yunsuk Choi, MD, Jae-Yong Kwak, MD PhD, Jeong-A Kim, MD PhD, Kyoo Hyung Lee, MD PhD, Yeung-Chul Mun, MD, Won Sik Lee, MD PhD, Myung Hee Chang, MD, Jinny Park, MD PhD, Jihyun Kwon, MD, Dong-Wook Kim

Blood (2019) 134 (Supplement_1): 1643.

https://doi.org/10.1182/blood-2019-126376

Published: 2019

Journal Articles

DDX41 mutation in Patients with Idiopathic Cytopenia of Undetermined Significance, Myelodysplastic Syndrome, and Acute Myeloid Leukemia

Eun-Ji Choi, MD, Young-Uk Cho, MD, Seongsoo Jang, Chan-jeoung Park, Han-Seung Park, MD, Jung-Hee Lee, MD PhD, Kyoo Hyung Lee, MD PhD, Eun-Hye Hur, PhD, Nayoung Kim, PhD, Hee Jeong Ouk, MD, Je-Hwan Lee, MD PhD

Blood (2019) 134 (Supplement_1): 3002.

https://doi.org/10.1182/blood-2019-129906

Published: 2019

Journal Articles

Mutational Characteristics and Changing Pattern from Idiopathic Cytopenia of Undetermined Significance to High-Risk Myelodysplastic Syndrome Stratified By IPSS-R

Eun-Ji Choi, MD, Young-Uk Cho, MD, Seongsoo Jang, Chan-jeoung Park, Han-Seung Park, MD, Jung-Hee Lee, MD PhD, Kyoo-Hyung Lee, MD PhD, Eun-Hye Hur, PhD, Nayoung Kim, PhD, Hee Jeong Ouk, MD, Je-Hwan Lee, MD PhD

Blood (2019) 134 (Supplement_1): 3009.

https://doi.org/10.1182/blood-2019-125236

Published: 2019

Journal Articles

Clinical Implications of Copy Number Variant Detection from Panel-Based Next-Generation Sequencing Data in Myelodysplastic Syndrome

Je-Hwan Lee, MD PhD, Yoo-Jin Kim, MD PhD, Seung-Hyun Jung, Eun-Hye Hur, Eun-Ji Choi, MD, Kyoo Hyung Lee, MD PhD, Seon-Hee Yim, Hye-Jung Kim, Yong-Rim Kwon, Young-Woo Jeon, MD PhD, Sug Hyung Lee, Yeun-Jun Chung

Blood (2019) 134 (Supplement_1): 4264.

https://doi.org/10.1182/blood-2019-131570

Published: 2019

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Severe Idiopathic Aplastic Anemia Older Than 40y

Hawk Kim, MD PhD, Yunsuk Choi, MD, Sung-Soo Yoon, MD PhD, Soo-Mee Bang, MD PhD, Hyeoung-Joon Kim, MD PhD, Sang Kyun Sohn, MD PhD, Yeung-Chul Mun, Young Rok Do, PhD MD, Yong Park, MD, Ji Hyun Lee, MD PhD, Sung Hwa Bae, MD, Ho Sup Lee, MD, Min Kyoung Kim, MD PhD, Won-Sik Lee, Jeong-Yeal Ahn, MD, Kyoo-Hyung Lee, MD PhD

Blood (2018) 132 (Supplement 1): 3876.

https://doi.org/10.1182/blood-2018-99-116190

Published: 2018

Journal Articles

Decitabine Versus Intensive Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Eun-Ji Choi, MD, Je-Hwan Lee, MD PhD, Han-Seung Park, MD, Jung-Hee Lee, MD PhD, Miee Seol, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Ji Min Woo, Kyoo Hyung Lee, MD PhD

Blood (2018) 132 (Supplement 1): 2713.

https://doi.org/10.1182/blood-2018-99-116102

Published: 2018

Journal Articles

Pilot Prospective Phase II Study of Nilotinib Combined with Chemotherapy for Myeloid Blastic Phase of Chronic Myeloid Leukemia or Acute Myeloid Leukemia with BCR/ABL1

Hawk Kim, MD PhD, Yunsuk Choi, MD, Sung-Soo Yoon, MD PhD, Won-Sik Lee, Jee Hyun Kong, MD, Kyoo-Hyung Lee, MD PhD, Jeong-Yeal Ahn, MD, Sang Kyun Sohn, MD PhD

Blood (2018) 132 (Supplement 1): 3020.

https://doi.org/10.1182/blood-2018-99-116488

Published: 2018

Journal Articles

Androgen Therapy for Lower-Risk Myelodysplastic Syndrome

Eun-Ji Choi, MD, Je-Hwan Lee, MD PhD, Han-Seung Park, MD, Jung-Hee Lee, MD PhD, Miee Seol, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Ji Min Woo, Kyoo Hyung Lee, MD PhD

Blood (2018) 132 (Supplement 1): 1823.

https://doi.org/10.1182/blood-2018-99-115931

Published: 2018

Journal Articles

Inhibition of DNA Methyltransferases By Volasertib in HMA Resistant Cell Lines

Sun-Hye Ko, MD PhD, Eun-Hye Hur, PhD, Bon-Kwan Goo, Juhyun Moon, Eun-ji Choi, MD, Han-Seung Park, MD, Kyoo Hyung Lee, MD PhD, Jung-Hee Lee, MD PhD, Je-Hwan Lee, MD PhD

Blood (2017) 130 (Supplement 1): 4991.

https://doi.org/10.1182/blood.V130.Suppl_1.4991.4991

Published: 2017

Journal Articles

Fludarabine/Melphalan 100 Conditioning Therapy Followed By Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis

Han-Seung Park, MD, Jung-Hee Lee, MD PhD, Je-Hwan Lee, MD PhD, Eunji Choi, MD, Sun-Hye Ko, MD PhD, Miee Seol, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Kyoo Hyung Lee, MD PhD

Blood (2017) 130 (Supplement 1): 2033.

https://doi.org/10.1182/blood.V130.Suppl_1.2033.2033

Published: 2017

Journal Articles

Intravenous Busulfan-Based Conditioning Regimens in Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Lymphoblastic Leukemia

Sun-Hye Ko, MD PhD, Jung-Hee Lee, MD PhD, Han-Seung Park, MD, Je-Hwan Lee, MD PhD, Eun-ji Choi, MD, Miee Seol, Young-Shin Lee, RN, Young-Ah Kang, Mijin Jeon, Kyoo Hyung Lee, MD PhD

Blood (2017) 130 (Supplement 1): 3214.

https://doi.org/10.1182/blood.V130.Suppl_1.3214.3214

Published: 2017

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Lymphoma: Baseline and Post-Transplant Prognostic Factors

Sun-Hye Ko, MD PhD, Jung-Hee Lee, MD PhD, Je-Hwan Lee, MD PhD, Han-Seung Park, MD, Eun-Ji Choi, MD, Young-Shin Lee, MS, Young-Ah Kang, MS, Kyoo-Hyung Lee, MD PhD

Blood (2016) 128 (22): 5858.

https://doi.org/10.1182/blood.V128.22.5858.5858

Published: 2016

Journal Articles

Role of Daunorubicin Dose Intensification for Induction Therapy in Acute Myeloid Leukemia Patients with FLT3-ITD Mutants

Eun-Ji Choi, MD, Je-Hwan Lee, MD PhD, Jung-Hee Lee, MD PhD, Han-Seung Park, MD, Sun-Hye Ko, MD PhD, Miee Seol, MS, Ji Min Woo, Kyoo-Hyung Lee, MD PhD

Blood (2016) 128 (22): 4033.

https://doi.org/10.1182/blood.V128.22.4033.4033

Published: 2016

Journal Articles

Treatment Outcomes and Prognostic Factors of Patients with Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Yunsuk Choi, MD PhD, Jung-Hee Lee, MD PhD, Kyoo-Hyung Lee, MD PhD, Han-Seung Park, MD, Eunji Choi, MD, Sun-Hye Ko, MD PhD, Miee Seol, R.N., Young-Shin Lee, MS, Young-Ah Kang, MS, Mijin Jeon, R.N., Je-Hwan Lee, MD PhD

Blood (2016) 128 (22): 4004.

https://doi.org/10.1182/blood.V128.22.4004.4004

Published: 2016

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Acute Myelogenous Leukemia in Remission - a Prospective Comparison of Three Different Donor Groups; Matched Sibling, Matched Unrelated, and Haploidentical Family Donors

Kyoo-Hyung Lee, MD PhD, Je-Hwan Lee, MD PhD, Jung-Hee Lee, MD PhD, Dae-Young Kim, MD PhD, Han-Seung Park, MD, Eun-Ji Choi, MD, Young-Shin Lee, MS, Young-Ah Kang, MS, Mijin Jeon, MS, Miee Seol, MS, Seung-Hyun Baek, RN, Hawk Kim, MD, Jae Hoo Park, MD, Jae-Cheol Jo, MD PhD, Yoon-Sook Choi, MD, Young-Don Joo, MD, Sung-Nam Lim, MD

Blood (2015) 126 (23): 4379.

https://doi.org/10.1182/blood.V126.23.4379.4379

Published: 2015

Journal Articles

Identification of Novel Fusion Genes and Differentially Expressed Genes in Acute Leukemia through Transcriptome Analysis

Dong-Hyun Lee, MD, Young-Uk Cho, MD PhD, Seongsoo Jang, MD PhD, Chan-Jeoung Park, MD PhD, Mi Hyun Bae, MD PhD, Dae-Young Kim, MD PhD, Jung-Hee Lee, MD PhD, Je-Hwan Lee, MD PhD, Kyoo-Hyung Lee, MD PhD, Jong Jin Seo, MD PhD, Eul-Ju Seo, MD PhD

Blood (2015) 126 (23): 1220.

https://doi.org/10.1182/blood.V126.23.1220.1220

Published: 2015

Journal Articles

Frequency, Characteristics and Prognostic Significance of RUNX1 mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified

Mi-Hyun Bae, MD PhD, Young-Uk Cho, MD PhD, Bohyun Kim, Dong Hyun Lee, Seongsoo Jang, MD PhD, Eul-Ju Seo, MD PhD, Chan-Jeoung Park, MD PhD, Dae-Young Kim, MD PhD, Jung-Hee Lee, MD PhD, Je-Hwan Lee, MD PhD, Kyoo-Hyung Lee, MD PhD, Yoon Hwan Chang, In-Suk Kim

Blood (2015) 126 (23): 3860.

https://doi.org/10.1182/blood.V126.23.3860.3860

Published: 2015

NARROW

HM43239, a Novel Small Molecule Inhibitor of FLT3, in Acute Myeloid Leukemia (AML) with and without FMS-like Tyrosine Kinase 3 (FLT3) Mutations: Phase 1/2 Study

Machine Learning-Based Approach to Predict Survival after Allogeneic Hematopoietic Cell Transplantation in Hematologic Malignancies

HM43239, a Novel Potent Small Molecule FLT3 Inhibitor, in Acute Myeloid Leukemia (AML) with FMS-like Tyrosine Kinase 3 (FLT3) Mutations: Phase 1 /2 Study

Long-Term Outcomes of Chronic Myeloid Leukemia Patients Who Lost Undetectable Molecular Residual Disease (UMRD) after Imatinib Discontinuation: Korean Imatinib Discontinuation Study (KIDS)

DDX41 mutation in Patients with Idiopathic Cytopenia of Undetermined Significance, Myelodysplastic Syndrome, and Acute Myeloid Leukemia

Mutational Characteristics and Changing Pattern from Idiopathic Cytopenia of Undetermined Significance to High-Risk Myelodysplastic Syndrome Stratified By IPSS-R

Clinical Implications of Copy Number Variant Detection from Panel-Based Next-Generation Sequencing Data in Myelodysplastic Syndrome

Allogeneic Hematopoietic Cell Transplantation for Severe Idiopathic Aplastic Anemia Older Than 40y

Decitabine Versus Intensive Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Pilot Prospective Phase II Study of Nilotinib Combined with Chemotherapy for Myeloid Blastic Phase of Chronic Myeloid Leukemia or Acute Myeloid Leukemia with BCR/ABL1

Androgen Therapy for Lower-Risk Myelodysplastic Syndrome

Inhibition of DNA Methyltransferases By Volasertib in HMA Resistant Cell Lines

Fludarabine/Melphalan 100 Conditioning Therapy Followed By Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis

Intravenous Busulfan-Based Conditioning Regimens in Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Lymphoblastic Leukemia

Allogeneic Hematopoietic Cell Transplantation for Lymphoma: Baseline and Post-Transplant Prognostic Factors

Role of Daunorubicin Dose Intensification for Induction Therapy in Acute Myeloid Leukemia Patients with FLT3-ITD Mutants

Treatment Outcomes and Prognostic Factors of Patients with Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Hematopoietic Cell Transplantation for Acute Myelogenous Leukemia in Remission - a Prospective Comparison of Three Different Donor Groups; Matched Sibling, Matched Unrelated, and Haploidentical Family Donors

Identification of Novel Fusion Genes and Differentially Expressed Genes in Acute Leukemia through Transcriptome Analysis

Frequency, Characteristics and Prognostic Significance of RUNX1 mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only